One of our latest publications highlights Southern Research’s innovative screening approach for identifying new influenza A inhibitors.

Next stop: Boston for two dynamic meetings focused on advancing cancer treatment—Immunotherapies Xchange and Antibody Drug Conjugates Xchange. If you're attending next week, reach out and connect—we'd love to share what we're working on.

We hope you had a chance to connect with the Southern Research team at #ASCO25 in Chicago!.Thank you to everyone who stopped by Booth #37107—we look forward to continuing the dialogue and building momentum.

Southern Research is heading to Chicago for the 2025 ASCO Annual Meeting. As we engage with the greater oncology community, we're committed to sharing our latest research and learning from others to enhance outcomes. Visit us at Booth #37107 to connect and explore opportunities.

Our team is constantly learning and growing — today, Amir Rafie represented us at the SOT Northern Cali event. Staying current with emerging science is vital to delivering impactful nonclinical safety solutions for new therapeutic modalities.

Every data point builds the bridge from curiosity to cure. On Clinical Trials Day, Southern Research salutes the rigorous science that reveal how therapies work and speed their path to patients.

Cutting-edge chemistry meets urgent medical need: our own Omar Moukha-Chafiq and Corinne Augelli-Szafran have helped uncover a potent, selective, orally bioavailable LRRK2 inhibitor, now detailed in the Journal of Medicinal Chemistry.

If you’re looking for a meaningful summer opportunity for your high schooler, Biotech Academy, from our STEM program, might be what you’re looking for. Learn more and register today—space is limited: .For more information: STEM@southernresearch.org.

Greetings from Chicago! We are proud to be at AACR, where the global cancer research community convenes to share groundbreaking discoveries and foster collaboration. If you're attending, find us at Booth #2540. We'd love to connect!

Cheers to a great evening and an even greater community! Thank you to all who joined SR at our happy hour during #WVC2025 in D.C. It was a joy to share stories, ideas, and a few laughs with so many of you. We’re grateful for the connections—and we’ll see you again next year!

We are thrilled to be in Washington, D.C., for #WVC2025 and connect with global leaders, exploring the future of medical countermeasures and sharing insights from our latest work. Are you heading to WVC today? Find our team & get details on our happy hour this evening!

We are on the ground at the Society of Toxicology Annual Meeting and ready to connect! Our team is showcasing the latest advancements in toxicology and drug development. Come visit Booth #851 to learn our latest research and capabilities & explore partnership opportunities.

We are excited to attend the SOT Annual Meeting & ToxExpo in Orlando, FL. This event brings together leading experts in toxicology, and we look forward to connecting, sharing insights, and exploring the latest advancements in the field.

Since breaking ground in the summer of 2022, we've been eagerly anticipating the opening of our new state-of-the-art facility—set to open in July 2025.

We are proud to be a driving force in Alabama's tech and biotech ecosystem. Learn how we're fostering innovation and supporting the growth of this exciting sector.

This $44 million grant will revolutionize the Birmingham Biotechnology Hub. Learn how this investment will accelerate drug development, create jobs, and improve healthcare access for all Alabamians.

We are very excited to share that the U.S. Economic Development Administration has awarded the Birmingham Biotechnology Hub $44M across five projects! .

After 50 years of dedicated service, Samuel L. Perry, Sr. is retiring. We are incredibly grateful for his contributions to our mission, hard work, and dedication.

Our Director of Oncology, Rebecca Boohaker, & our Head of A.I. Drug Discovery, Sixue Zhang, along with their coworkers including Anwar Ullah, published a new work on an oncogenic protein, GLI1:

We continue to be proud of Dr. Corinne Augelli-Szafran, a Southern Research leader, for being named a 2024 Fellow of the National Academy of Inventors.